RedCarpetLife
496
In the world today
Hasmukh Chudgar & family

Hasmukh Chudgar & family

H. family
-1.3% | - $-100.00M
$7.61 B ₹ 69,803 Cr
Real Time Net Worth #496 Ranking as of 01 Mar 2026 By Forbes

More on Hasmukh Chudgar & family

Gender

Male

Age

93Y

Country

India

Born On

January, 1933

Deceased

No

Relationship Status

Married

Children

3

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Pharmaceuticals)

Primary Organization

Intas Pharmaceuticals

Titles

Founder

Sources of Wealth

Intas Pharmaceuticals

Industry

Pharmaceuticals, Healthcare

About Hasmukh Chudgar & family


H asmukh Chudgar is an Indian self-made billionaire and the founder of Intas Pharmaceuticals, one of India's largest and most successful privately held pharmaceutical companies. A trained pharmacist, he started his career working for other companies before taking the entrepreneurial leap in 1977 to start his own small drug manufacturing business in Ahmedabad.

He has since built Intas into a major global player in the pharmaceutical industry. The company has a strong presence in the generic drug market and has also built a significant business in biopharmaceuticals. He has expanded the company's footprint globally, with a network of subsidiaries and manufacturing plants in Europe and other parts of the world. He has since handed over the day-to-day management of the company to his sons, Binish and Nimish, but he remains the patriarch and founder of the multi-billion dollar enterprise he built from scratch.

Advertisement

Quick Reads


  • Founder of the Indian pharmaceutical giant Intas Pharmaceuticals.
  • A self-made billionaire, he started the company in 1977.
  • Intas is one of the largest private drugmakers in India.
  • He is a pharmacist by training.
  • His two sons now run the day-to-day operations of the company.

Early Life and Background


Hasmukh Chudgar is an Indian businessman, the self-made billionaire Founder of Intas Pharmaceuticals, one of India's most successful pharmaceutical companies. His career is rooted in science: he is a graduate in pharmacy from Gujarat University and recognized the immense, untapped market for high-quality, affordable generic drugs globally.

In 1977, he laid the foundation of Intas Pharmaceuticals in Ahmedabad, Gujarat. His philosophy centers on innovation, quality, and making essential drugs accessible to a broader population, both in India and internationally. This commitment to scientific integrity and affordability became the foundation of his multi-billion dollar fortune.

Career Journey of Hasmukh Chudgar & family


Hasmukh Chudgar's strategic leadership transformed Intas Pharmaceuticals from a small generic drug manufacturer into a global powerhouse. The company achieved massive vertical integration, creating specialized divisions, including an independent biotechnology division (Intas Biopharmaceuticals) in 2000 (focused on biosimilar products and monoclonal antibodies). The company's expansion was driven by strategic global acquisitions (e.g., acquiring Teva Pharmaceuticals' U.K. and Ireland assets).

Today, Intas generates $2.3 billion in annual revenue and employs over 24,000 people. Chudgar has successfully transitioned leadership to the next generation: his three sons, Nimish (Joint MD and CEO), Binish (Vice Chairman and Joint MD), and Urmish (Joint MD, a haematologist-oncologist who heads the biopharma division), now helm the company's operations. His wealth is tied to the long-term, stable profitability of the global generic and biopharmaceutical sector.

Advertisement

Hasmukh Chudgar & family's Timeline


1977:

Founds Intas Pharmaceuticals in Ahmedabad, Gujarat (Founding).

1985:

The company is incorporated (Corporate Milestone).

2000:

The Biologics Unit is incorporated (Scientific Diversification).

Ongoing:

Successfully transitions leadership to his three sons (Generational Succession).

Ongoing:

Intas achieves $2.3 billion in annual revenue and employs 24,000+ people (Executive Oversight).

Major Business Ventures and Investments


Hasmukh Chudgar's wealth is concentrated in his founding and controlling ownership of the private pharmaceutical giant, Intas Pharmaceuticals.

  • Intas Pharmaceuticals (Founder): The core private asset, a global leader in generic drugs, antiviral drugs, and biopharmaceuticals (brands include Accord Healthcare). Revenue reached $2.3 billion in FY24.
  • Biopharma Specialization: His son, Urmish, heads the division focused on biosimilar products and recombinant DNA.
  • Strategic Acquisitions: The company acquired major assets from Teva Pharmaceuticals and Sanofi (Fawdon Plant) in Europe.
  • Family Governance: Leadership is successfully transitioned to his three sons.

Advertisement

Philanthropy and Social Impact


Hasmukh Chudgar's social impact is massive and structural, tied to Intas Pharmaceuticals' role in providing high-quality, affordable essential medications to billions of people globally. The company provides thousands of stable, high-value industrial and technical jobs in India and internationally.

His personal philanthropy supports various community and educational initiatives, reflecting his strong adherence to entrepreneurial and Jain values.

Fashion, Style, and Lifestyle


Hasmukh Chudgar maintains the professional, composed style of an Indian industrial patriarch. His attire is consistently formal and high-quality, favoring traditional Indian business attire or tailored suits. His aesthetic reflects simplicity and integrity, adhering to strong entrepreneurial and family values.

Residing in Ahmedabad, Gujarat, India, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to industrial scale, scientific excellence, and the long-term, stable growth of the global generic drug sector.

Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He founded Intas Pharmaceuticals in 1977, a global leader in generic drugs and biopharmaceuticals.
  • He holds a degree in pharmacy from Gujarat University.
  • His three sons now helm the company's operations.
  • Intas has acquired major assets from Teva Pharmaceuticals and Sanofi in Europe.
  • His son, Urmish, is a haematologist-oncologist who heads the biopharma division.
  • The company’s annual revenue reached $2.3 billion in FY24.
  • His wealth is tied to the successful globalization of Indian generic drug manufacturing.

Advertisement

More Profiles


Robert Duggan

-0.45% | -$51.17M

Luc Tack

+0.75% | +$9.41M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content